HSBC and 6 other SEBI-registered analysts issued 20 long term recommendations across 8 stocks for long-term portfolio allocation, with a bullish bias.
HSBC and 6 other SEBI-registered analysts issued 20 equity long term recommendations today, targeting multi-month to multi-year investment horizons. The batch carries a bullish bias — 20 buys against 0 sells — covering 8 stocks.
The 5 most-covered names of the session:
HDFCAMC drew 12 calls — 12 buy calls — from HSBC, with entries between ₹2,414 and ₹2,447 and targets at ₹2,590.
WOCKPHARMA attracted 2 buys from STOCKGAINERSS (SEBI Reg. INH100007879) at ₹2,200 targeting ₹2,400 and ₹2,700 (stop ₹2,010).
ANTELOPUS was flagged for a buy by Motilaloswalofficial (SEBI Reg. INH000000412) at ₹1,189.95, targeting ₹1,295.5 — a potential upside of +8.9%, with a stoploss at ₹1,138. The risk-to-reward ratio stands at 1:2.0.
ASAHIINDIA was flagged for a buy by Vikas Sethi (SEBI Reg. INH000000834) at ₹950, targeting ₹1,125 — a potential upside of +18.4%, with a stoploss at ₹870. The risk-to-reward ratio stands at 1:2.2.
CANFINHOME was flagged for a buy by Manas Jaiswal (SEBI Reg. INH100001625) at ₹797.6, with a stoploss at ₹770.
The remaining 3 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — CENTUM (₹4,392.5 → ₹4,590) via Integratedresearchchannel; INFY (₹1,032 → ₹1,050) via JP Morgan; TATASTEEL (₹189.15 → ₹197) via Integratedresearchchannel.
This roundup reproduces calls from 7 SEBI-registered Research Analysts: HSBC (SEBI Reg. INH000001287); Integratedresearchchannel (SEBI Reg. INH200006530); STOCKGAINERSS (SEBI Reg. INH100007879); JP Morgan (SEBI Reg. INH000001873); Manas Jaiswal (SEBI Reg. INH100001625); Motilaloswalofficial (SEBI Reg. INH000000412); Vikas Sethi (SEBI Reg. INH000000834).
Long-term picks are best accumulated on dips. Investors should review fundamentals periodically and maintain position sizing discipline.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.